ImmunologybioRxivPreprint
Single-domain antibodies efficiently neutralize SARS-CoV-2 variants of concern, including Omicron variant
I. A. Favorskaya, D. V. Shcheblyakov, I. B. Esmagambetov…·A. L. Gintsburg
The paper identifies single-domain antibodies that neutralize SARS-CoV-2 variants, including Omicron, with enhanced potency through dimeric modifications.
DOI 10.1101/2021.11.24.469842